HemoCath Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

HemoCath General Information

Description

Developer of an integrated hemodynamic monitoring and diagnostic system intended for the diagnosis, treatment, and monitoring of acute heart failure. The company's platform integrates a specialized pulmonary artery catheter, which is designed for safer arm insertion and provides reliable, continuous monitoring of crucial values with cloud-based artificial intelligence capabilities that interpret complex data streams and deliver real-time, data-driven insights and clinical guidance, enabling clinical teams to enhance care management decisions, which concurrently improves patient recovery trajectories and lowers institutional expenses associated with hospital admissions and readmissions for heart failure.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Austin, TX
  • United States
Primary Industry
Monitoring Equipment
Other Industries
Decision/Risk Analysis
Corporate Office
  • Austin, TX
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HemoCath Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 17-Apr-2023 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2022 Completed Generating Revenue
1. Accelerator/Incubator 20-Aug-2021 Completed Generating Revenue
To view HemoCath’s complete valuation and funding history, request access »

HemoCath Patents

HemoCath Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020359681-A1 Multi-sensor catheter for right heart and pulmonary artery catheterization Inactive 30-Sep-2019
EP-4041071-A1 Multi-sensor catheter for right heart and pulmonary artery catheterization Inactive 30-Sep-2019
EP-4041071-A4 Multi-sensor catheter for right heart and pulmonary artery catheterization Inactive 30-Sep-2019
US-12402797-B2 Multi-sensor catheter for right heart and pulmonary artery catheterization Active 30-Sep-2019
US-20220338745-A1 Multi-sensor catheter for right heart and pulmonary artery catheterization Active 30-Sep-2019 A61B5/6853
To view HemoCath’s complete patent history, request access »

HemoCath Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HemoCath Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Medlim Accelerator/Incubator
Incubateur Impulse Accelerator/Incubator
BE Health Ventures Venture Capital Minority
To view HemoCath’s complete investors history, request access »

HemoCath FAQs

  • When was HemoCath founded?

    HemoCath was founded in 2013.

  • Where is HemoCath headquartered?

    HemoCath is headquartered in Austin, TX.

  • What is the size of HemoCath?

    HemoCath has 5 total employees.

  • What industry is HemoCath in?

    HemoCath’s primary industry is Monitoring Equipment.

  • Is HemoCath a private or public company?

    HemoCath is a Private company.

  • What is HemoCath’s current revenue?

    The current revenue for HemoCath is .

  • Who are HemoCath’s investors?

    Medlim, Incubateur Impulse, and BE Health Ventures have invested in HemoCath.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process